Minetta Liu

Minetta Liu at Mayo Clinic is a translational breast cancer researcher with expertise in circulating tumor DNA and minimal residual disease monitoring in early and metastatic TNBC. Her work has evaluated ctDNA dynamics as predictors of treatment response and recurrence in patients with TNBC receiving neoadjuvant chemotherapy. She has contributed to standardizing ctDNA assay platforms for clinical application in breast cancer. Her research is advancing the use of liquid biopsy to guide escalation and de-escalation of therapy in TNBC.